This HTML5 document contains 70 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q37134424

rdf:type

wikibase:Item

schema:description

videnskabelig artikel articolo scientifico artigo científico vědecký článek article scientifique artículu científicu espublizáu en 1993 vetenskaplig artikel wissenschaftlicher Artikel مقالة علمية نشرت في سبتمبر 1993 научни чланак vedecký článok scientific article published on September 1993 article científic wetenschappelijk artikel bilimsel makale bài báo khoa học наукова стаття, опублікована у вересні 1993

p:P577

wds:Q37134424-A600F5C0-0CB5-4686-A999-EA0F1D58B036

wdt:P577

1993-09-01T00:00:00Z

p:P407

wds:Q37134424-6A225709-202E-46AF-8D7C-28794E8EE12B

wdt:P407

wd:Q1860

p:P2860

wds:Q37134424-17EABA93-0E06-48D8-BCA9-9AFA0E76CC98 wds:Q37134424-CE3D3C1F-19AC-40B3-80A1-EB823A45A00B wds:Q37134424-B70B6D28-979A-4CC2-AC08-900495D7A4F3 wds:Q37134424-82AD0B8F-9348-4606-A405-A350BC60CF0C wds:Q37134424-88D9EB64-719D-4BB9-85DF-457229372044 wds:Q37134424-93CE4DB6-5CA5-4B4F-A7FF-CE426E8BBD55 wds:Q37134424-4081EEF6-75FC-47B8-8DBC-6E74D5D105BE

wdt:P2860

wd:Q44417042 wd:Q37115080 wd:Q37118146 wd:Q67875371 wd:Q34482770 wd:Q54271673 wd:Q37284399

p:P2093

wds:Q37134424-E1A600F0-0034-4B21-A7AC-D91149262153 wds:Q37134424-D8BD1485-8E5E-4C39-971A-B5145240704B

wdt:P2093

R N Jones M J Bale

rdfs:label

Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Grou Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Grou Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Grou

skos:prefLabel

Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Grou Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Grou Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Grou

schema:name

Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Grou Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Grou Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Grou

p:P1476

wds:Q37134424-BA502012-2F34-47B4-8E8F-6C206770B81A

wdt:P1476

Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Grou

p:P304

wds:Q37134424-5D83ED70-F4E7-45B2-B439-611FA5CCEA08

wdt:P304

2538-2540

p:P31

wds:Q37134424-54ABC142-565D-437B-9C65-98ED755D514F

wdt:P31

wd:Q13442814

p:P921

wds:Q37134424-09D25049-DA30-422B-9616-9E859D5BAB75 wds:Q37134424-29C59F08-1EE4-43A3-8F52-80A42A96CDF0

wdt:P921

wd:Q827792 wd:Q1453445

p:P698

wds:Q37134424-F887D33B-1523-449E-8D45-CB9F0EF3727B

wdtn:P698

n11:8408586

wdt:P698

8408586

p:P1433

wds:Q37134424-B3C1A4A5-A8E6-4338-AF71-BEAB3A008DAA

wdt:P1433

wd:Q4041880

p:P433

wds:Q37134424-063B14C5-593C-44BF-9675-F35A53075B14

p:P478

wds:Q37134424-0E855A16-B29A-4F5C-87E9-41D4B3801501

wdt:P433

9

wdt:P478

31

p:P932

wds:Q37134424-7A31CC5E-1604-4F5C-A490-04ACBF6DA97E

wdt:P932

265808